Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei City, Taiwan.
Metrics to compare | 4128 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship4128PeersSector | |
---|---|---|---|---|
P/E Ratio | −9.8x | −2.5x | 12.2x | |
PEG Ratio | 0.26 | 0.07 | 0.03 | |
Price/Book | 1.5x | 0.9x | 1.5x | |
Price / LTM Sales | 7.3x | 1.6x | 1.0x | |
Upside (Analyst Target) | - | 0.0% | 19.3% | |
Fair Value Upside | Unlock | 23.3% | 10.5% | Unlock |